Breaking AI & Tech News Analyzed

The Rise of Unregulated Stem Cell Treatments for Autism Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and potentially harmful "treatments" that scientists warn are proliferating across the US under the active encouragement of the US health secretary, Robert F Kennedy Jr. Clinics in Florida, Texas and other states are selling what they bill as "regenerative medicine" to families with autistic children who have intensive care needs. Parents who have taken their children through the process talked about their hopes and fears for a therapy that appears to be gaining ground in the US. The Mechanics of Questionable Stem Cell Procedures The procedure, which can involve the child being sedated with ketamine before receiving intravenous doses of millions of stem cells, costs up to $20,000 for each treatment. Families are often advised to return for regular top-ups. Profoundly stressed parents are being wooed to the clinics with promises that a high-dose infusion of umbilical cord stem cells can lead to dramatic improvements in their children's ability to speak, socialise, or avoid aggressive or self-harming behaviour. Yet there is no scientific evidence that the procedure works – the most comprehensive clinical trial staged so far, a placebo experiment conducted by Duke University, found insignificant benefits for most of the 180 children tested. The US Food and Drug Administration (FDA) directly cautions parents that if they are being offered stem cell treatments outside an approved clinical trial, "you are likely being deceived and offered a product illegally". Financial Impact of the Unregulated Treatment Market The burgeoning market for unproven stem cell treatments represents a significant financial burden on families already dealing with the high costs of autism care. Treatments can cost up to $20,000 per session, with many providers recommending multiple treatments over time. Among the providers is Better Stem, a Miami-based company run by Greice Murphy, which charges $300 for an initial consultation followed by up to $15,000 per infusion. The company claims to be the first in the US offering "legal, compliant access" to stem cell therapies under the "right-to-try" law, despite autism not meeting the legal definition of a terminal illness covered by that legislation. Families like Taylor and her four-year-old son Ollie from Utah are raising funds through donations to cover the $12,500 cost of a single treatment, highlighting the desperate financial sacrifices parents are making for these unproven therapies. Regulatory Erosion and Shifting Healthcare Landscape In his 16 months as the secretary of the Department of Health and Human Services within the Trump administration, Kennedy has undercut established scientific endeavors. He has fired thousands of federal health officials, dismissed longstanding scientific advisers, defunded $31m in autism-related research and attempted to shrink the recommended list of childhood vaccinations. At the same time, largely unnoticed, he has given his backing to alternative health providers moving to fill the gap. Kennedy appeared by video link at the first two annual summits held in San Diego by Autism Health, a leading advocate of stem cell infusions for autistic kids. Those providers include Mike Chan, a Malaysian physician who presented the San Diego summit with a protocol that involves injecting autistic children in the buttocks with high doses of stem cells extracted from slaughtered sheep and rabbits. Kennedy described the organiser of the San Diego summit, Tracy Slepcevic, as a "good friend" and appointed her to his remodelled Autism Coordinating Committee, which guides federally funded autism research. Future Outlook for Autism Treatment Regulation The proliferation of unproven stem cell treatments for autism appears likely to continue, with a new clinical trial planned to involve 120 autistic children in Mexico, a country that has historically taken a looser approach to stem cell regulation than the US. Ed Clay, founder of the Cellular Performance Institute in Tijuana, said the clinical trial would be free to families and fully licensed under the Mexican federal health authority, Cofepris. He claimed his team includes "21 PhD scientists and 42 medical doctors, including PhDs from institutions such as Harvard, Yale, MIT and Stanford". While Clay said the clinical trial could potentially be imported to US sites under full FDA licensing if early results are promising, other stem cell providers operating in this space may not hold such standards. Clay himself acknowledged: "I would say our biggest competitor right now for CPI is the scammer and the many fly-by-night clinics operating in this space." Despite Kennedy's stated desire to prevent a "wild west" of alternative therapies, his administration's actions suggest a continued expansion of unregulated treatments, potentially leaving vulnerable families exposed to financial exploitation and medical risks without scientific validation.

The LeadA police officer in Derbyshire is under criminal investigation for allegedly using artificial intelligence to create evidential material in a number of cases, in what is believed to be the first known instance of its kind in the United Kingdom. The officer has been removed from frontline duties pending the outcome of the investigation.The Investigation DetailsThe Derbyshire police force confirmed that a criminal investigation has been launched into allegations of perverting the course of justice after the alleged use of AI systems by an officer to create evidential material. The force stated it is working closely with the Crown Prosecution Service regarding any potentially impacted cases.According to authorities, the investigation is still in its early stages, and no further details are currently available. The officer involved has been removed from frontline duties, but no arrests have been made at this time. The specific role of the officer or the exact nature of the suspected misconduct has not been disclosed.Broader Context of AI in PolicingThis investigation follows recent warnings about the reliability of AI systems in police work. Alex Murray, head of the National Police Chiefs' Council's Police AI centre, revealed that several police forces had been instructed to stop using AI systems to prepare court statements and other tasks due to concerns about their reliability.In April 2026, the Metropolitan police launched investigations into hundreds of officers after using an AI tool built by the US tech company Palantir. The software was deployed to surveil staff members using readily available data, uncovering various rule-breaking violations from work-from-home infractions to suspected corruption and criminal allegations.Implications for Law EnforcementThe case raises significant questions about the increasing integration of artificial intelligence in criminal justice systems and the potential consequences when these technologies are misused. The involvement of the Crown Prosecution Service indicates the seriousness of the allegations, as they work with defense teams and courts to address potentially affected cases.This incident highlights the growing tension between technological innovation and ethical boundaries in law enforcement. As AI becomes more prevalent in policing, authorities must balance efficiency gains with the need for transparency, accountability, and reliability in systems that impact people's lives and liberties.Future Outlook for AI in PolicingFollowing this investigation, we can expect increased scrutiny of AI tools used by police forces across the UK. There may be calls for clearer guidelines, regulatory frameworks, and oversight mechanisms to ensure that AI applications in law enforcement are both effective and ethically sound.The case could also influence how other countries approach the integration of AI in their criminal justice systems. As technology continues to evolve, law enforcement agencies worldwide will need to develop robust policies that prevent misuse while still harnessing the potential benefits of artificial intelligence in policing.

The Internal Conflict Over Grok's Safety ProtocolsDevin Kim, a former engineer at Elon Musk’s xAI who now leads a thinktank focused on AI safety, has filed a lawsuit in California state court alleging he was fired from the SpaceX subsidiary for raising concerns about the risks artificial intelligence poses to humanity. Kim claims his efforts to place guardrails on the development of the chatbot Grok made him a target for company leadership.The lawsuit details that Kim was one of the initial hires at xAI in 2024 and was promoted to a key leadership position months after joining. He alleges that his supervisor, xAI co-founder Jimmy Ba, flouted directives to implement safety mechanisms and rejected Kim's insistence on appropriate testing. Kim claims he was abruptly fired last September, just before he was set to present on AI safety to company leadership.Alleged Retaliation: Kim claims Musk expected xAI to implement safety testing, but leadership prioritized speed over safety.Timing: The lawsuit was filed just days before SpaceX’s planned initial public offering, the largest ever.Claims: Kim argues that xAI’s failure to prioritize safety virtually guaranteed the company would commit unlawful acts, from discrimination to weapons proliferation.Regulatory Fallout: The Scale of Grok's Deepfake CrisisThe lawsuit comes at a time when xAI’s Grok chatbot is facing intense international scrutiny. An official Canadian watchdog report confirmed that Grok violated privacy laws by launching an image-generation tool that allowed users to create non-consensual, sexualized deep fakes. Following a formal investigation in January, xAI announced tweaks to prevent the editing of images of real people in revealing clothing.Research indicates the scale of the issue was massive. According to the Center for Countering Digital Hate, Grok produced approximately 23,000 sexualized images of children over an 11-day period in December and January. Furthermore, the chatbot generated millions of AI-altered sexualized images earlier this year, many created using photos of women without their consent. This has led to a growing list of countries, including Britain and Canada, cracking down on the explicit content generated by the model.Global Scrutiny: Multiple nations are investigating Grok for violating privacy and safety standards.Child Safety: Estimates suggest Grok generated over 23,000 images of children in a short timeframe.Company Response: Musk has denied any knowledge of child sexual abuse material, stating he was "not aware of any naked underage images generated by Grok. Literally zero."Implications for SpaceX's Upcoming IPO and AI GovernanceThe legal battle between Kim and xAI poses significant risks to SpaceX as it prepares for its IPO on Friday. The lawsuit accuses the companies of retaliation and wrongful discharge in violation of California law, seeking unspecified monetary damages. This adds a layer of regulatory and reputational risk to the largest IPO in history.The allegations challenge Musk’s narrative that xAI was established as a "safer alternative" to OpenAI. A jury recently rejected Musk’s own lawsuit claiming OpenAI had strayed from its mission, but this new case suggests internal dissent regarding safety protocols is deepening within Musk's AI ventures. The conflict highlights a growing tension between rapid AI development and the implementation of rigorous safety guardrails.The Future of AI Safety in Musk's EcosystemAs xAI faces mounting international investigations and internal whistleblower lawsuits, the future of AI governance within Musk's ecosystem appears increasingly volatile. The lawsuit suggests a corporate culture where safety concerns are met with termination rather than mitigation. Moving forward, investors and regulators will likely scrutinize xAI’s internal safety protocols more closely, potentially delaying or complicating the SpaceX IPO. For Musk, the challenge will be balancing his vision for aggressive AI development with the legal and ethical obligations required to prevent the proliferation of harmful content like deepfakes and non-consensual imagery.

The Enduring Legacy of David Hockney David Hockney's art was a feast of unabashed visual pleasure, one long orgy of the gaze, the delighted lifelong epiphany of someone who cherished flowers in a vase and freeways in the sun and thought endlessly about new ways of making pictures of such passing treasures. He changed the world just by looking at it. Hockney's Vision of Paradise The most revealing fact about Hockney is that he loved LA. Where some might see a moronic inferno, he saw freedom and possibility under an unjudging blue sky. Low-lying houses with patio doors glinting vacantly, tall thin palm trees with tiny heads, the white spume of a diver's splash – Hockney's California is a vision of paradise. The Intersection of Art and Life Pop art had a miserable streak a Chevrolet wide. Most of its great exponents – Richard Hamilton, Andy Warhol, Gerhard Richter – were not fans but cold critics of the new western consumer society that was taking shape by 1960. Then along came Hockney. A childhood in the smoke-blackened industrial landscape of Bradford produced a young artist as free from nostalgia as he was from snobbery. A Master of Observation By the end of the 1960s, an eerie stillness dominated his paintings as he became more openly the observer, the looker-on. The loneliness of looking is the theme of what may be his greatest painting, Portrait of an Artist (Pool with Two Figures). It's certainly his most expensive, selling in 2018 for $90.3m. A Celebration of Life and Art Hockney once took me around a Caravaggio exhibition at the National Gallery to demonstrate why he believed the painter must have used some kind of early camera. Then at his London residence, he produced a Japanese scroll to show how eastern landscape art uses shifting, unfurling viewpoints that are much more embracing of the world's scale than the single-point perspective that has obsessed western art.

Guardian's Mid‑Year Album roundup for 2026The British newspaper has published an interactive compilation titled “The best albums of 2026 so far,” giving music fans a curated view of the year’s standout releases up to June.Interactive list format and editorial criteriaThe piece is built as an interactive atom, allowing users to scroll through album entries, view cover art, and read brief editorial comments. While the exact selection methodology is not detailed in the excerpt, the Guardian typically bases its choices on critical reception, cultural impact, and genre diversity.Absence of quantitative metrics in the current releaseThe provided HTML contains no sales figures, streaming numbers, or chart positions, indicating the list prioritises qualitative assessment over hard data at this stage.Implications for the music industry and listenersBy spotlighting a range of artists early in the year, the roundup can influence streaming playlists, radio programming, and festival bookings. It also offers emerging musicians visibility alongside established acts, reinforcing the Guardian’s role as a tastemaker.What to watch for in the second half of 2026As the year progresses, the interactive will likely be updated to reflect new releases and shifting critical consensus. Observers can expect the list to evolve, potentially incorporating end‑of‑year awards and broader audience metrics.

A Celebration of Artistic VersatilitySally Beamish marks her 70th year with 'House of Wonder,' an album that encapsulates her remarkable journey as a musician who seamlessly navigates between classical, jazz, and folk traditions. The album is not just a collection of compositions but a deeply personal statement featuring collaborations with family members and close friends, centered around Beamish's masterful viola performances.The Intimate Creation of 'House of Wonder'The album derives its name from the summerhouse where Beamish would retreat to compose, a space that has now been immortalized through music. This personal sanctuary becomes the creative heart of the project, with each piece reflecting different facets of her life and relationships. The album opens with 'April,' a luminous chaconne for viola and accordion that serves as a memorial to her friend, jazz pianist Ellis Marsalis Jr., demonstrating her ability to bridge classical and jazz traditions.Musical Diversity and Personal Narratives'House of Wonder' showcases Beamish's chameleon-like ability to adapt to various musical styles while maintaining her distinctive voice. The album features several autobiographical pieces: 'Crescent,' a trio for viola, piano and trumpet inspired by family games in Islington, offset by what she describes as her father's emotional absence; and 'Gerropaedie,' a Satie-inspired birthday gift for an elderly patron that brings poignant intimacy to the collection.Family Collaborations and Artistic LegacyWhat makes this album particularly special is the involvement of Beamish's family members, each contributing to this celebration of her life and art. Her son Laurie provides 'Lurk,' a sly, spiky tango for accordion and viola, while her other son Tom contributes the mournful 'Where You Are.' Her daughter Stephanie writes, plays, and sings 'House of Wonder,' and her husband Peter Thomson adds bluesy vocals to 'Night Songs.' These collaborations create a tapestry of familial love and artistic respect.A New Chapter in Beamish's Distinguished CareerAt 70, Beamish continues to demonstrate why she is regarded as one of contemporary classical music's most innovative voices. 'House of Wonder' stands as a testament to her enduring creativity and her ability to find inspiration in personal relationships and memories. As she enters this new decade of her life, the album suggests that her artistic evolution shows no signs of slowing, promising further explorations at the intersections of musical traditions and personal expression.

The Shift in London's Air Quality Strategy Low emission zones have historically faced significant political and public resistance, often criticized for their economic impact. However, a new study conducted by researchers at Imperial College London offers compelling evidence that these environmental policies are delivering tangible health dividends. The research analyzed health records to determine if the introduction of the T-charge and the subsequent Ultra-Low Emission Zone (Ulez) in central London correlated with a reduction in hospital admissions. The Mechanics of the Policy Transition The study focused on the timeline of London's clean air initiatives. The T-charge, an additional congestion charge for older, polluting vehicles, was introduced in 2017. This was a precursor to the more comprehensive central London Ulez, which launched in 2019. Dr. Rosemary Chamberlain, the lead researcher, emphasized the importance of isolating the effect of these schemes from other variables. Quantifying the Health Impact The data reveals a distinct shift in hospital admission trends following the implementation of these zones. Before the schemes, emergency admissions in central London were increasing at a rate of 3% per year. Following the launch of the T-charge and Ulez, this trend reversed, with emergency admissions decreasing by 3% per year. Heart Conditions: An 8% reduction in emergency admissions for heart problems was observed. Respiratory Issues: A 6% reduction in emergency admissions for breathing problems was recorded. Redefining Urban Policy and Public Health The researchers controlled for other potential factors, such as changes in healthcare-seeking behavior and the broader impact of the Covid-19 pandemic, to ensure the findings were attributable specifically to the emission reduction initiatives. While respiratory outcomes showed a downward trend, it did not reach statistical significance in this specific adult-only analysis, though the researchers noted that children are more susceptible to these effects. A Blueprint for Future Cities The study provides a strong argument for the adoption of clean air zones globally. Dr. Daniela Fecht highlighted that while factors like increased cycling and reduced traffic noise may contribute, the primary driver of these health improvements is the reduction in air pollution. This research suggests that the economic and social costs of implementing low-emission zones are outweighed by the significant public health benefits, potentially setting a new standard for urban environmental policy.

Ebola has spread to new areas of north‑eastern Democratic Republic of Congo, including the densely populated Kpanga displacement camp, raising alarms that the outbreak is entering a more dangerous, community‑driven phase.Outbreak Extends to New Northeastern Communities and Displacement CampThe World Health Organization reported that the virus, the rare Bundibugyo strain, is now being detected in health zones across Ituri, North Kivu and South Kivu provinces on a near‑daily basis. Senior WHO epidemiologist Olivier le Polain warned that local transmission is now evident beyond travel‑linked cases.Case Numbers Reveal Accelerating Scale of the Crisis689 confirmed cases since the outbreak was declared on May 15139 deaths among confirmed cases119 suspected cases reported by the United NationsNeighbouring Uganda has recorded 19 cases and 2 deathsHumanitarian and Regional Risks Amplify Amid Weak Health InfrastructureOvercrowded camps such as Kpanga, where hundreds share a single toilet, create fertile conditions for rapid contagion. The DRC government’s limited oversight, ongoing rebel activity, and damaged health facilities hinder isolation‑bed capacity and contact‑tracing efforts, leaving “blind spots” in high‑risk zones.International aid workers, including Caitlin Brady of the Danish Refugee Council, warn that panic‑driven displacement could spread the virus beyond the border, threatening regional stability.What the Next Weeks May Hold for Containment EffortsWHO officials stress that scaling up surveillance, securing isolation spaces, and accelerating vaccine trials for the Bundibugyo strain are critical. Without rapid improvements, the outbreak could expand further into refugee settlements and neighboring countries.

The Market Rebound Stock markets have surged following US President Donald Trump’s announcement that he called off planned strikes against Iran and a peace deal with Tehran is imminent. Wall Street’s benchmark S&P500 index finished nearly 1.8 percent higher on Thursday, ending a three-day streak of losses for the biggest single-day gain since April. The tech-focused Nasdaq Composite jumped 2.5 percent, while the older, blue-chip Dow Jones Industrial Average gained about 1.9 percent. Global Market Performance The rally continued in the Asia Pacific on Friday, with markets in Japan, South Korea, Taiwan, Hong Kong, and Australia racking up gains. South Korea’s Kospi surged more than 8 percent in morning trading. Japan’s benchmark Nikkei 225 rose as much as 4 percent. Taiwan’s TAIEX gained about 2.4 percent. Australia’s ASX 200 rose about 1.8 percent. In Hong Kong, the Hang Seng Index was up more than 1 percent. Oil Prices and Trump’s Statement Brent crude, the primary international benchmark for oil prices, fell about 1 percent to below $89.50 a barrel on hopes for a return to normality in the Strait of Hormuz. Trump on Thursday suggested that a deal to end the war on Iran could be signed as soon as this weekend. “We just made a great settlement of the war with Iran… subject to finalisation of documents,” Trump told reporters in the Oval Office of the White House. Future Market Outlook Iran has not publicly confirmed Trump’s claims, but a Ministry of Foreign Affairs spokesman told reporters a memorandum of understanding with the US is “under consideration”. “For the rally to be sustained, investors will want to not only see the actual deal being signed, but a complete reopening of the Strait of Hormuz,” Khoon Goh, head of Asia research for ANZ Bank, told Al Jazeera.